Table 3. Summarized FET results.
A | ||||||||
Ct—2n = 150 | CKD—2n = 188 | FET results | After adjustment for sex and age | |||||
Genetic factors | Relative frequency (%) | p | OR | 95% CI | p | OR | 95% CI | |
HLA-G*01:01 UTR-4 haplotype | 14.67 | 7.45 | 0.035 | 0.468 | 0.231–0.950 | 0.032 | 0.480 | 0.199–0.961 |
MICA-129 Val/Met genotype | 53.33 | 37.23 | 0.043 | 0.519 | 0.280–0.962 | 0.131 | --- | --- |
B | ||||||||
KTN—n = 36 | KTR—n = 28 | FET results | After adjustment for sex | |||||
Genetic factors | Relative frequency (%) | p | OR | 95% CI | p | OR | 95% CI | |
+3187 AG | 25.00 | 53.57 | 0.037 | 3.461 | 1.201–9.978 | --- | --- | |
+3142 CG | 25.00 | 67.86 | <0.001 | 6.333 | 2.120–18.924 | 0.013 | 5.357 | 1.417–20.261 |
+3010 CG | 25.00 | 67.86 | <0.001 | 6.333 | 2.120–18.924 | 0.013 | 5.357 | 1.417–20.261 |
+3010 GG | 33.33 | 10.71 | 0.041 | 0.240 | 0.060–0.957 | 0.041 | 0.136 | 0.016–1.178 |
FET: Fisher’s Exact Test. Ct: Control group. CKD: Patients with chronic kidney disease. OR: Odds Ratio. CI: Confidence Interval.